16
Participants
Start Date
March 31, 2013
Primary Completion Date
June 30, 2015
Study Completion Date
July 31, 2016
Oxytocin
Subjects will be administered 40 IUs of oxytocin nasal spray or matching placebo prior to two individual sessions of MET.
Saline
Subjects will be administered 40 IUs of oxytocin nasal spray or matching placebo prior to two individual sessions of MET.
Medical University of South Carolina, Charleston
Medical University of South Carolina
OTHER